IQVIA believes in the UK’s potential to be a unique bioscience centre of excellence within the life sciences space, and our investment announced in the Second Life Sciences Sector Deal further supports the UK Government and the industry’s aim to ensure this potential is realised. It is also IQVIA’s mission to drive healthcare forward through world-leading clinical trials and real world evidence providing domain expertise, transformative technology and advanced analytics including artificial intelligence.
To learn more:
IQVIA's collaboration with Genomics England to co-develop the platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients is a critical step in advancing genomic research. This alliance will enable faster and more efficient drug research, more robust evidence to support treatment value, and greater access to personalized medicines; whilst protecting patient privacy.
To learn more:
IQVIA has taken a leading role in addressing data access challenges by partnering in the development and validation of the Simulacrum. The Simulacrum is a simulated oncology dataset structured to model properties of the data collected within the Cancer Analysis System (CAS), but which contains no actual patient data. IQVIA has formulated the Oncology Insights Simulator, which uses the Simulacrum to conduct real world studies leveraging one of the largest and most detailed population-based cancer databases in the world. Through this innovative approach, IQVIA can perform clinically relevant and statistically precise studies that answer critical questions about cancer patients and their treatments without compromising patient confidentiality.
To learn more:
In collaboration with EMIS Health, IQVIA launched the EMIS App Library by AppScript, enabling more than half of GP surgeons in England to to recommend apps to millions of patients.
By fully appreciating and leveraging clinicians’ real world activity, we accomplish our vision of Human Data Science, where every clinical decision can be made based on credible and robust evidence. This technology has the potential to drive significant cost savings for the NHS through improved prevention and management of chronic conditions and support the delivery of clinical research goals as set out in the NHS Long Term Plan, contributing to make the NHS the world’s most advanced primary healthcare system with respect to the delivery of digitally enabled care.
Driven by passion for a healthier world, our teams continue to innovate and develop new solutions to advance healthcare. Below are a few examples of projects where boundaries were pushed and health outcomes improved.
